Date published: 2026-11-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP3A Antibody (D-2): sc-271033

5.0(2)
Write a reviewAsk a question
Datasheets
  • CYP3A Antibody (D-2) is a mouse monoclonal IgG1 κ, cited in 6 publications, provided at 200 µg/ml
  • raised against amino acids 204-503 mapping at the C-terminus of CYP3A of human origin
  • recommended for detection of all CYP3A family members of mouse, rat and human origin by WB, IP, IF and ELISA
  • m-IgG1 BP-HRP is the preferred secondary detection reagent for CYP3A Antibody (D-2) for WB applications. This reagent is now offered in a bundle with CYP3A Antibody (D-2) (see ordering information below).
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

CYP3A Antibody (D-2) is a mouse monoclonal IgG1 antibody that detects CYP3A in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). CYP3A is a crucial member of the cytochrome P450 family, primarily involved in the metabolism of a wide range of drugs, making CYP3A essential for pharmacokinetics and drug interactions. CYP3A is predominantly located in the liver, gastrointestinal tract, and kidneys, which are key organs for drug metabolism and excretion. CYP3A localization in these tissues directly influences the bioavailability and clearance of therapeutic agents, thereby impacting drug efficacy and safety. The CYP3A gene cluster, which includes CYP3A4, CYP3A5, CYP3A7, and CYP3A43, is responsible for metabolizing over 50% of all clinical drugs, highlighting CYP3A′s importance in personalized medicine and the need for careful monitoring of drug interactions. The CYP3A cluster is mapped to the gene locus 7q22.1, and understanding CYP3A expression and regulation can provide insights into individual variations in drug metabolism, ultimately guiding more effective treatment strategies.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.

Download thiomersal SDS

CYP3A Antibody (D-2) References:

  1. Functional gene variants of CYP3A4.  |  Werk, AN. and Cascorbi, I. 2014. Clin Pharmacol Ther. 96: 340-8. PMID: 24926778
  2. CYP3A4-mediated pharmacokinetic interactions in cancer therapy.  |  Tian, D. and Hu, Z. 2014. Curr Drug Metab. 15: 808-17. PMID: 25705904
  3. Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia.  |  Yuan, X., et al. 2020. Drug Metab Rev. 52: 225-234. PMID: 32270716
  4. CYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 Cells.  |  Yang, W., et al. 2023. Drug Metab Dispos. 51: 492-498. PMID: 36623883
  5. CYP3A4*22 may increase bleeding risk in ticagrelor users.  |  Liedes, H., et al. 2023. Basic Clin Pharmacol Toxicol. 133: 202-207. PMID: 37162098
  6. Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib.  |  Cardona, P., et al. 2024. Clin Pharmacol Drug Dev. 13: 810-818. PMID: 38421129
  7. Effects of total saikosaponins on CYP3A4 and CYP1A2 in HepaRG cells.  |  Tang, Y., et al. 2024. Exp Ther Med. 27: 217. PMID: 38590569
  8. Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms.  |  Riffi, R., et al. 2024. CNS Neurol Disord Drug Targets. 23: 1463-1473. PMID: 38859787
  9. CYP3A4-Mediated Metabolic Activation and Cytotoxicity of Chlortoluron.  |  Guo, X., et al. 2024. Chem Res Toxicol. 37: 1104-1112. PMID: 38885202
  10. Omeprazole Induces CYP3A4 mRNA Expression but Not CYP3A4 Protein Expression in HepaRG Cells.  |  Fujita, Y., et al. 2024. Biol Pharm Bull. 47: 1218-1223. PMID: 38925922

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

CYP3A Antibody (D-2)

sc-271033
200 µg/ml
$322.00

CYP3A Antibody (D-2): m-IgG1 BP-HRP Bundle

sc-542674
200 µg Ab; 20 µg BP
$361.00

I need to use an antibody to detect the protein in samples of bovine origin. Do you know if sc-271033: CYP3A (D-2) mouse monoclonal antibody will work?

Asked by: AbPolly
Please contact our Technical Service Department and we would be happy to perform sequence analysis and review our data to answer any questions you may have about additional species reactivity.
Answered by: Technical Support
Date published: 2017-03-06
  • y_2026, m_11, d_17, h_7CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.50
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_271033, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 100ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by ET from WB published in rat liver samplesWB published in rat liver samples. -SCBT Publication Review
Date published: 2015-02-02
Rated 5 out of 5 by JM from Good Western blot data obtained in mouseGood Western blot data obtained in mouse liver and human liver tissue extracts. -SCBT QC
Date published: 2014-02-03
  • y_2026, m_11, d_18, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.50
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_271033, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT
CYP3A Antibody (D-2) is rated 5.0 out of 5 by 2.
  • y_2026, m_11, d_18, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.50
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_271033, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 109ms
  • REVIEWS, PRODUCT